Literature DB >> 3021860

Elevated levels of human collagenase inhibitor in blister fluids of diverse etiology.

H G Welgus, E A Bauer, G P Stricklin.   

Abstract

Blister fluids from a variety of bullous disorders were examined for the presence of human collagenase inhibitor. A protein immunologically identical to the collagenase inhibitor produced by human skin fibroblasts was found in high concentrations within bullae of diverse etiologies. Levels of collagenase inhibitor in blister fluids ranged from 0.9-12.5 micrograms/ml, averaging 4.9 micrograms/ml. The mean values were 3- to 4-fold greater than those present in the sera of corresponding patients and exceeded plasma levels by 6- to 8-fold. The time course of collagenase inhibitor accumulation in blister fluid was studied using heat- and suction-induced bullae. The concentration in newly formed blisters was approximately 0.5 micrograms/ml, virtually identical to plasma inhibitor levels, and remained constant for approximately 4 h. Inhibitor concentrations then rose rapidly, reaching peak values of approximately 6 micrograms/ml after 48 h. We speculate that the role of this inhibitor in blister fluid involves the inhibitions of active proteinases within the bulla cavity and may occur to limit the extent of blister formation or to assist in wound repair.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021860     DOI: 10.1111/1523-1747.ep12455837

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis.

Authors:  Camilo S Zurita-Salinas; Edgar Krötzsch; Lino Díaz de León; Jorge Alcocer-Varela
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631

2.  A critical role for neutrophil elastase in experimental bullous pemphigoid.

Authors:  Z Liu; S D Shapiro; X Zhou; S S Twining; R M Senior; G J Giudice; J A Fairley; L A Diaz
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

3.  Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.

Authors:  Zhi Liu; Ning Li; Luis A Diaz; Michael Shipley; Robert M Senior; Zena Werb
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

4.  Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid.

Authors:  Lan Lin; Tomoko Betsuyaku; Lisa Heimbach; Ning Li; David Rubenstein; Steven D Shapiro; Lijia An; George J Giudice; Luis A Diaz; Robert M Senior; Zhi Liu
Journal:  Matrix Biol       Date:  2011-09-25       Impact factor: 11.583

5.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.

Authors:  M Ståhle-Bäckdahl; M Inoue; G J Guidice; W C Parks
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 6.  The pathophysiology of bullous pemphigoid.

Authors:  Michael Kasperkiewicz; Detlef Zillikens
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

7.  Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds.

Authors:  G P Stricklin; L Li; V Jancic; B A Wenczak; L B Nanney
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

8.  Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma.

Authors:  U K Saarialho-Kere; E S Chang; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

9.  The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis.

Authors:  Agnieszka Zebrowska; Joanna Narbutt; Anna Sysa-Jedrzejowska; Jozef Kobos; Elzbieta Waszczykowska
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

10.  Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid.

Authors:  Z Liu; J M Shipley; T H Vu; X Zhou; L A Diaz; Z Werb; R M Senior
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.